Assessment of cardiovascular risk and simultaneous treatment of multiple risk factors is important in patients with metabolic syndrome

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.9, 2008-09, pp. : 13-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic Syndrome: Cardiovascular Risk Assessment and Management

By Wong Nathan D.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 259-272

Adis International

Access to resources Recommend Favorite

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 5025-5038

Bentham Science Publishers

Access to resources Recommend Favorite

The Prevalence of the Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 104-111

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Cardiovascular Risk Factors in Women

By  

Current Medicinal Chemistry, Vol. 22, Iss. 31, 2015-10 ,pp. : 3580-3596

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Syndrome: Prevalence and Risk Factors in Southern China

By Li J-B   Wang X   Zhang J-X   Gu P   Zhang X   Chen C-X   Guo R   Wu M  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1142-1148

Field House Publishing

Access to resources Recommend Favorite